期刊文献+

重组CD13单链抗体/蝎毒素AGAP原核表达质粒的构建 被引量:1

Study on construction of recombinant prokaryotic expression plasmid of AGAP and CD13scFv
下载PDF
导出
摘要 目的:构建pRSETA/AGAP/CD13scFv重组表达质粒,为重组CD13单链抗体/蝎毒素AGAP融合蛋白的表达奠定实验基础。方法:利用RT-PCR法从东亚钳蝎尾腺中获得AGAP目的基因,并与克隆质粒TOPO载体连接转入DH5α菌,用EcoR I和Hind III将目的基因从克隆质粒上切下并与同样双酶切后的表达质粒pRSETA连接;在含CD13单链抗体(CD13scFv)的pSecTag2HygroC/CD13-1/RFP质粒中获得CD13scFv目的基因,用EcoR I、Xho I双酶切并与同样双酶切后的pRSETA/AGAP连接转入DH5α菌,提取重组质粒进行酶切及测序鉴定。结果:目的基因AGAP与表达质粒pRSETA连接,成功构建了pRSETA/AGAP重组质粒;目的基因CD13scFv再与该重组质粒连接,成功构建了pRSETA/AGAP/CD13scFv。结论:AGAP目的基因能经RT-PCR法获得,并能成功与表达质粒连接,构建pRSETA/AGAP;目的基因CD13scFv能由pSecTag2HygroC质粒中获得,并成功与pRSETA/AGAP连接,得pRSETA/AGAP/CD13scFv重组质粒。为该重组质粒体外融合蛋白的表达及今后研究CD13scFv和蝎毒素AGAP协同性杀伤CD13阳性肿瘤细胞提供了良好的实验基础及理论依据。 Objective: To construct recombinant prokaryotic expression plasmid pRSETA/AGAP/CD13scFv that contributes to the expression of fusion protein AGAP/CD13scFv. Methods: The AGAP gene was obtained from Buthus martensii Karsch using RT-PCR, then it was connected to the cloning from the recombinant cloning plasmid, and connected to the expression plasmid pRSETA that was digested by the same enzymes. Subsequently, CD13scFv was amplified from plasmid pSecTag2HygroC with PCR and inserted into vector pRSETA/AGAP. At last, the recombinant plasmid was identified by PCR, enzyme digestion analysis and sequencing. Results: The recombinant expression plasmid pRSETA/ AGAP/CD13scFv was constructed successfully. Conclusion: The objective gene AGAP can be obtained from Buthus martensii Karsch using RT-PCR. CD13scFv can be amplified from plasmid pSecTag2HygroC with PCR. And the recombinant prokaryotic expressing plasmid pRSETA/AGAP/CD13scFv are successfully constructed. The construction of pRSETA/AGAP/CD13scFv has a great constribution not only to the exDression of fusion nrotein, but also to the theranv of CD13 nositive tumors.
出处 《温州医学院学报》 CAS 2009年第3期213-216,共4页 Journal of Wenzhou Medical College
基金 浙江省自然科学基金资助项目(Y206383)
关键词 CD13 单链抗体 蝎毒素 AGAP 质粒 肿瘤 CD13 single-chain antibody scorpion toxin AGAP plasmid tumor
  • 相关文献

参考文献7

  • 1吴旭辉.CD13靶向治疗研究进展[J].癌症进展,2006,4(2):163-166. 被引量:6
  • 2Liu YF,Hu J,Zhang JH,et al.Isolation,purification,and N-terminal partial sequence of an antitumor peptide from the venom of the Chinese scorpion Buthus martensii[J].Prep Biochem Biotechnol,2002,32(4):317-327.
  • 3Liu YF,Ma RL,Wang SL,et al.Expression of an antitumor-analgesic peptide from the venom of Chinese scorpion Buthus martensii karsch in Escherichia coli[J].Protein Expr Purif,2003,27(2):253-258.
  • 4Suzuki M,Takayanagi A,Shimizu N.Targeted gene delivery using humanized single-chain antibody with negatively charged oligopeptide tail[J].Cancer Sci,2004,95(5):424-429.
  • 5Wen WH,Liu JY,Qin WJ,et al.Targeted inhibition of HBV gene expression by single-chain antibody mediated small interfering RNA delivery[J].Hepatology,2007,46(1):84-94.
  • 6Wen WH,Qin WJ,Gao H.An hepatitis B virus surface antigen specific single chain of variable fragment derived from a natural immune antigen binding fragment phage dis-play library is specifically internalized by HepG2.2.15 cells[J].J Viral Hepat,2007,14(7):512-519.
  • 7Ashmun RA,Look AT.Metalloprotease activity of CD13/ aminopeptidase N on the surface of human myeloid cells[J].Blood,1990,75(2):462-469.

二级参考文献23

  • 1[19]Ichinose Y,Genka K,Koike T,et al:Randomized doubleblind placebo-controlled trial of bestatin in patients with resected stage I squamous-cell lung carcinoma.J Natl Cancer Inst,2003,95 (8):605
  • 2[20]Furuse K,Fukuoka M,Genka K,et al:Double blind controlled study of ubenimex (Bestatin) against squamous cell lung cancer--a multicenter cooperative study.Gan To Kagaku Ryoho,1993,20 (9):1187
  • 3[21]Tokuhara T,Adachi M,Hashida H,et al.Neutral endopeptidase/CD10 and aminopeptidase N/CD13 gene expression as a prognostic factor in non-small cell lung cancer.Jpn J Thorac Cardiovasc Surg,2001,49 (8):489
  • 4[22]Ota K,et al.Results of investigation into prognosis immunotherapy with bestatin for acute nonlymphocytic leukemia in adults.Jpn J Cancer Chem,1986,13:1017
  • 5[23]Ota K,Ogawa N.Randomized controlled study of chemoimmunotherapy with bestatin of acute nonlymphocytic leukemia in adults.BiomedPharm,1990,44 (2):93
  • 6[1]Richard A.Ashmun and A.Thomas Look.Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells.Blood,1990,75 (2):462
  • 7[2]Riemann D,Kehlen A,Lungner J.CD13-not just a marker in leukemia typing.Immunol Today,1999,20:83
  • 8[3]Bordessoule D,Jones M,Gatter KC,and Mason DY.Immunohistological patterns of myeloid antigens:Tissue distribution of CD13,CD14,CD16,CD31,CD36,CD65,CD66,and CD67.Br J Haematol,1993,83:370
  • 9[4]Alliot F,Rutin J,Leenen PJ,and Pessac B.Pericytes and periendothelial cells of brain parenchyma vessels co-express aminopeptidase N,aminopeptidase A,and nestin.J Neurosci Res,1999,58:367.
  • 10[5]Kawai M,Otake Y,Hara Y.High-molecular-mass isoform of aminopeptidase N/CD13 in serum from cholestatic patients.Clin Chim Acta,2003,330 (1-2):141

共引文献5

同被引文献17

  • 1张涛,徐文方.以金属蛋白酶APN/CD13为靶点的抗癌药物的化学生物学研究[J].中国药物与临床,2004,4(9):660-663. 被引量:5
  • 2郝好杰,凌贤龙,徐元基,杜芝燕,王妍,陈惠华,陆应麟.带红色荧光蛋白靶向线粒体载体的构建与表达[J].生物技术通讯,2005,16(4):371-373. 被引量:1
  • 3吴旭辉.CD13靶向治疗研究进展[J].癌症进展,2006,4(2):163-166. 被引量:6
  • 4Bhagwat SV, Lahdenranta J, Giordano R, et al. CD13/APN isactivated by angiogenic signals and is essential for capillarytube formationfJ]. Blood, 2001, 97(3):652-659.
  • 5Petrovic N, Schacke W,Gahagan JR, et al. CD13/APN regu-lates endothelial invasion and filopodia formation[J]. Blood,2007, 110(1):142-150.
  • 6Proost P, Mortier A, Loos T, et al. Proteolytic processingof CXCLll by CD 13/aminopeptidase N impairs CXCR3and CXCR7 binding and signaling and reduces lymphocyteand endothelial cell migration[Jj. Blood, 2007, 110(1):37-44.
  • 7Wivel NA, Wilson JM. Methods of gene delivery[J],Hematol Oncol Clin North Am, 1998,12(3):483-501.
  • 8Na N, Chen K, Zhang J, et al. Tumor antigen-pulsed CD8 a(+) dendritic cells induce T cell-mediated graft-versus-tu-mor effect in vitro [J]. J Huazhong University Sci TechnolMed Sci, 2011, 31(6):728-734.
  • 9Ikeda N, Nakajima Y, Tokuhara T,et al. Clinical signifi-cance of aminopeptidase N/CD13 expression in human pan-creatic carcinoma[J]. Clin Cancer Res, 2003, 9(4):1503-1508.
  • 10Bhagwat SV, Lahdenranta J, Giordano R, et al. CD13/APN isactivated by angiogenic signals and is essential for capillarytube formation[J]. Blood, 2001,97(3):652-659.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部